Esophageal Diseases  >>  matuzumab (EMD 72000)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
matuzumab (EMD 72000) / Takeda, EMD Serono
MATRIX EG, NCT00215644 / 2005-000146-36: Matuzumab Treatment With Epirubicin, Cisplatin and Capecitabine (ECX) in Esophago-Gastric Cancer

Completed
2
72
Europe
Matuzumab, EMD 72000, Epirubicin, Cisplatin, Capecitabine
Merck KGaA, Darmstadt, Germany
Esophageal Cancer, Gastric Cancer
07/08
08/08

Download Options